HealthCare Global Enterprises Appoints Gopi Lama as Head of Domestic Sales

1 min read     Updated on 12 Sept 2025, 08:19 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
Overview

Healthcare Global Enterprises Limited (HCG) has appointed Mr. Gopi Lama as the new Head of Domestic Sales, effective September 15, 2025. The Board of Directors approved the appointment based on the Nomination and Remuneration Committee's recommendation. Mr. Lama brings over 30 years of healthcare experience, including 13 years in hospital operations. He has previously worked with major healthcare organizations like Apollo, Fortis, and Narayana Health. His achievements include driving cluster revenues beyond INR 700.00 crore and expertise in sales operations and brand strategy.

19234206

*this image is generated using AI for illustrative purposes only.

Healthcare Global Enterprises Limited (HCG), a leading provider of specialized healthcare services in India, has announced the appointment of Mr. Gopi Lama as the new Head of Domestic Sales. The appointment, effective September 15, 2025, marks a significant addition to HCG's senior management team.

Board Approval and Appointment Details

According to a regulatory filing by HCG to the National Stock Exchange of India and BSE Limited, the Board of Directors approved Mr. Lama's appointment based on the recommendation of the Nomination and Remuneration Committee. The decision was made during a board meeting held on September 12, 2025, which lasted from 4:30 PM to 6:30 PM IST.

Extensive Experience in Healthcare

Mr. Gopi Lama brings over three decades of valuable experience to his new role at HCG. His career spans various aspects of the healthcare sector, with a particular focus on hospital operations for more than 13 years. Prior to joining HCG, Mr. Lama has held key positions in some of India's most prominent healthcare organizations, including Apollo, Fortis, Narayana Health, and SRCC Children's Hospital.

Impressive Track Record

Throughout his career, Mr. Lama has demonstrated exceptional skills in driving business growth and managing high-performing teams. Some of his notable achievements include:

  • Driving cluster revenues beyond INR 700.00 crore
  • Expertise in sales operations and brand strategy
  • Successful consultant empanelment initiatives
  • Strong stakeholder engagement skills

Strategic Appointment for HCG

The appointment of Mr. Gopi Lama as Head of Domestic Sales is expected to strengthen HCG's market position and drive its sales strategies. His extensive experience in hospital operations, combined with his proven track record in revenue generation and team leadership, aligns well with HCG's growth objectives.

HealthCare Global Enterprises Limited, known for its specialization in cancer care and other tertiary care services, continues to expand its presence across India. The addition of Mr. Lama to the senior management team is likely to contribute significantly to the company's domestic sales efforts and overall business development.

As HCG moves forward with this strategic appointment, stakeholders will be watching closely to see how Mr. Lama's expertise and leadership will impact the company's performance in the competitive healthcare market.

Morgan Stanley, Nippon India MF Lead Rs 438 Crore Share Purchase in HealthCare Global

1 min read     Updated on 11 Sept 2025, 09:41 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
Overview

Morgan Stanley, Nippon India Mutual Fund, Motilal Oswal MF, and Plutus Wealth Management collectively purchased 63 lakh equity shares (4.52% stake) of Healthcare Global Enterprises (HCG) for Rs 438.00 crore. The shares were priced at Rs 695.00 each on the National Stock Exchange. CVC Capital Partners' affiliate, Aceso Company Pte Ltd, was the seller, reducing its holding from 8.76% to 4.24%. This transaction follows KKR's recent agreement to acquire up to 54% stake in HCG from CVC Capital Partners for approximately USD 400 million.

19152681

*this image is generated using AI for illustrative purposes only.

Healthcare Global Enterprises (HCG), one of India's largest oncology hospital chains, saw a significant shift in its shareholding pattern as major institutional investors acquired a substantial stake in the company.

Key Highlights

  • Morgan Stanley, Nippon India Mutual Fund, Motilal Oswal MF, and Plutus Wealth Management collectively purchased 63 lakh equity shares of HCG.
  • The transaction was valued at Rs 438.00 crore, with shares priced at Rs 695.00 each on the National Stock Exchange.
  • The acquired stake represents 4.52% of HCG's equity.
  • CVC Capital Partners, through its affiliate Aceso Company Pte Ltd, was the seller in this transaction.
  • Aceso Company's holding in HCG decreased from 8.76% to 4.24% following the sale.

Transaction Details

The open market transaction saw four prominent institutional investors stepping in to acquire a significant stake in HealthCare Global Enterprises. The details of the transaction are as follows:

Particulars Details
Buyers Morgan Stanley, Nippon India Mutual Fund, Motilal Oswal MF, Plutus Wealth Management
Seller Aceso Company Pte Ltd (affiliate of CVC Capital Partners)
Number of shares 63 lakh
Price per share Rs 695.00
Total transaction value Rs 438.00 crore
Stake acquired 4.52%

Market Response

Following the news of this substantial transaction, HCG's stock price experienced a slight dip. The shares closed at Rs 685.95, down 1.31% from the previous close.

Recent Developments

This transaction comes in the wake of a significant announcement made in February. KKR, a global investment firm, had revealed agreements to acquire up to a 54% equity stake in HCG from CVC Capital Partners. The deal, valued at approximately USD 400 million, is set to make KKR the largest shareholder in the healthcare company.

About HealthCare Global Enterprises

HealthCare Global Enterprises, founded in 1989, has established itself as a prominent player in India's healthcare sector, particularly in oncology services. The company operates an extensive network of 25 medical care centres spread across 19 cities in India. This wide reach has positioned HCG as one of the country's largest oncology hospital chains, providing specialized cancer care services to patients across the nation.

The recent share transactions and the upcoming change in majority ownership underscore the attractiveness of HCG in the healthcare investment landscape, potentially setting the stage for further growth and expansion in India's rapidly evolving healthcare sector.

More News on Healthcare Global Enterprises
Explore Other Articles